Explore evidence

15 %15% of young women receiving PrEP reported previously using HIV self-testing.

KenyaVIH/sidaobserved February to November 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 7 observations

300 dilution_ratioTwo superinfected individuals were able to neutralize variants from four different HIV-1 subtypes at plasma dilutions greater than 1:300.

KenyaVIH/sidapublished 2012PLoS pathogenseurope_pmcdocument of 3 observationsDOI 10.1371/journal.ppat.1002611

29.37 %L'incidence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 29,37 % en 2016.

KenyaVIH/sidaobserved 2016HAL · Unilimdocument of 747 observations

29.6 %The prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya was 29.6%.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 8 observations

7.2 %At 12 months postpartum, 96 women (7.2%) were lost-to-follow-up (LTFU).

KenyaVIH/sidapublished 2022Journal of the International AIDS Societyeurope_pmcdocument of 5 observations

At 12 months, there were no significant differences in mean CD4 count or viral load suppression between the intervention and control groups.

KenyaVIH/sidaobserved 12 monthspublished 2021Journal of acquired immune deficiency syndromes (1999)PubMed

0.48 ratioIn adjusted analyses, HIV prevalence among female sex workers accessing SWOP clinics in Nairobi in 2014 was associated with an adjusted prevalence ratio of 0.48 compared with 2008.

KenyaVIH/sidaobserved 2014published 2021AIDS (London, England)PubMeddocument of 13 observations

21 casesMajor drug resistance mutations were detected in samples from 21 (14.6%) of 144 participants.

KenyaVIH/sidapublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

2.3 %Fingerprint technology had a failure to enroll rate of 2.3% for unique patient matching and identification in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublished 2021Journal of medical Internet researchPubMeddocument of 11 observations

68 %By 2018, the estimated percentage of adolescent girls and young women who would know their HIV status was 68% if none were DREAMS invitees in Gem, western Kenya.

KenyaVIH/sidaobserved 2018published 2022AIDS (London, England)PubMeddocument of 11 observations

21 percentage_pointsStandardized patient actor training resulted in an adjusted mean difference of 21.0 percentage points in guideline adherence score for preexposure prophylaxis (PrEP) care between intervention and control sites.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 9 observations

16.3 %In the Standard APS arm, 16.3% (232/1422) of partners tested were newly diagnosed with HIV.

KenyaVIH/sidaobserved 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations

2.4 odds_ratioA unit increase in V3 loop's net-charge increased the odds of a virus being CXCR4-tropic by 2.4 times.

KenyaVIH/sidapublished 2022MedicinePubMeddocument of 6 observations

80 %Among people with HIV and blood pressure ≥160/100 mmHg who enrolled in the intervention (n = 120), 80% were retained in care at 1 year.

Kenyahypertension artérielle · VIH/sidapublished 2025Journal of the International AIDS SocietyPubMeddocument of 11 observations

12.6 %At baseline, HIV prevalence was 12.6% in intervention communities.

KenyaVIH/sidapublished 2020AIDS (London, England)PubMeddocument of 8 observations

7.2 %After 6 months on antiretroviral therapy, median CD4% increased by 7.2% (IQR 2.0–11.6%) among children with HIV.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 5 observations

215 individualsA total of 215 HIV-negative and 108 HIV-positive men aged 18–35 years (median 26, IQR 23–30) were enrolled in the study.

KenyaVIH/sidapublished 2013PloS oneeurope_pmcdocument of 6 observations

31 %Performance monitoring explained 31% of outreach quality variation.

KenyaVIH/sidapublished 2025PloS onePubMeddocument of 8 observations

0.7 RRHaving higher adherence skills was associated with a relative risk of 0.70 for virologic non-suppression.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 6 observations

45 %45% of the adolescents and young adults living with HIV reported that disclosure positively influenced their clinic attendance.

KenyaVIH/sidaobserved 2019published 2023Frontiers in public healthPubMeddocument of 18 observations

2.3 prevalence_ratioThe prevalence ratio for internalized stigma associated with self-disclosure was 2.3 (95% CI: 1.1–4.6).

KenyaVIH/sidapublished 2021AIDS and behaviorPubMeddocument of 13 observations

-0.8 percentage_pointsThe difference in virological suppression at week 48 between long-acting and oral therapy groups was -0.8 percentage points.

KenyaVIH/sidapublished 2024The Lancet. Infectious diseasesPubMeddocument of 10 observations

10 %The proportion of proximal tubular renal dysfunction (PTRD) was 10.0% in the TDF group compared to 3.1% in the TDF-sparing group.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 8 observations

87.2 %Ever testing for HIV among respondents increased from 87.2% to 95.6% (p < 0.04).

KenyaVIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 10 observations

8 yearsMedian duration of antiretroviral therapy for PLHIV was 8 years.

KenyaVIH/sidapublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 8 observations